B
Medication Insurance Coverage Comparator
3.30
Derivation Chain
Step 1
Health data integrated interpretation
→
Step 2
Cost optimization of chronic disease medications
→
Step 3
Same-ingredient medications priced differently across hospitals
Problem
Chronic disease patients aged 50-65 (hypertension, diabetes, hyperlipidemia, etc.) receive prescriptions from 2-4 hospitals/pharmacies monthly, but the same active ingredient (brand-name vs generic) is prescribed differently at each hospital, creating a $15-38 monthly difference in out-of-pocket costs. Patients don't understand national health insurance coverage rules and copayment structures, and many don't even know they can request a switch to generics. They're missing $180-450 in annual medication cost savings.
Solution
Enter current medication names to compare insurance-covered prices and copayments for equivalent-ingredient alternatives. First, it searches by medication name for active ingredients and dosage, displaying the full list of brand-name and generic equivalents with their insurance-covered prices. Second, it calculates the monthly and annual copayment difference between current medications and the lowest-cost alternatives. Third, it generates a 'substitute medication request form' to show the doctor during appointments.
NUMR-V Scores
NUMR-V Scoring System
| N Novelty | 1-5 | How uncommon the service is in market context. |
| U Urgency | 1-5 | How urgently users need this problem solved now. |
| M Market | 1-5 | Market size and growth potential from proxy indicators. |
| R Realizability | 1-5 | Buildability for a small team with realistic constraints. |
| V Validation | 1-5 | Validation signal quality from competition and demand data. |
SaaS N=.15 U=.20 M=.15 R=.30 V=.20
Senior N=.25 U=.25 M=.05 R=.30 V=.15
Feasibility (73%)
Data Availability
20.6/25
Feasibility Breakdown
| Tech Complexity | / 40 | Difficulty of core implementation stack. |
| Data Availability | / 25 | Practical availability and cost of required data. |
| MVP Timeline | / 20 | Expected time to ship a usable MVP. |
| API Bonus | / 15 | Bonus for viable public API leverage. |
Market Validation (51/100)
Validation Breakdown
| Competition | / 20 | Signal quality from competitor landscape. |
| Market Demand | / 20 | Demand proxies from search and mention patterns. |
| Timing | / 20 | Fit with current shifts in tech, behavior, and regulation. |
| Revenue Signals | / 15 | Reference evidence for monetization viability. |
| Pick-Axe Fit | / 15 | How well the concept serves participants in a trend. |
| Solo Buildability | / 10 | Practicality for lean-team implementation. |
Technical Requirements
Frontend [low]
Backend [medium]